3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
4
Rhabdoid Tumor
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Neuroblastoma
4
Medulloblastoma
4
Lymphoma, Non-Hodgkin
4
Lymphoma
4
Histiocytosis, Langerhans-Cell
4
Hepatoblastoma
4
Glioma
4
Ependymoma
4
Sarcoma
3
Rhabdomyosarcoma
3
Osteosarcoma
3
Multiple Myeloma
3
Central Nervous System Neoplasms
3
Sarcoma, Ewing
2
Xanthogranuloma, Juvenile
1
Histiocytic Sarcoma
1
Familial ependymoma
1
Interventions
Trastuzumab
243
Paclitaxel
193
Cyclophosphamide
158
Docetaxel
134
Letrozole
113
Capecitabine
113
Fulvestrant
106
Doxorubicin
103
Bevacizumab
87
Carboplatin
81
exemestane
80
Anastrozole
79
Lapatinib
70
Tamoxifen
69
Albumin-Bound Paclitaxel
57
palbociclib
54
pertuzumab
53
Taxes
51
Gemcitabine
50
Radiotherapy
46
eribulin
43
pembrolizumab
41
Everolimus
41
Ado-Trastuzumab Emtansine
41
Vinorelbine
38
130-nm albumin-bound paclitaxel
35
ixabepilone
32
Epirubicin
28
pegfilgrastim
25
liposomal doxorubicin
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Breast Neoplasms
×
Nuclear Medicine Department, Hospital
×
Clear all
No trials found.